Biotech

Oxford and 2U Launch New Programme in AI-Driven Drug Discovery

Six-week executive education programme will train scientists and R&D professionals to apply AI across the drug discovery pipeline.

Andelyn to Scale Manufacturing for Genprex’s Diabetes Gene Therapy Programme

AAV-based therapy targeting pancreatic cells moves towards IND-enabling studies and future clinical manufacturing.

Carterra HT-SPR Helps Turn Anthropic’s Autonomous Protein Design Into Measurable Results

Carterra’s high-throughput SPR platforms help validate 1,320 AI-designed protein binders across 15 targets, highlighting the growing role of rapid experimental data in AI-driven drug discovery.

Hummingbird Bioscience wins APAC AI Discovery Award

Singapore-based Hummingbird Bioscience has been named the Asia Pacific Trailblazer Award winner at the 2026 Nebius AI Discovery Awards, recognising the company's AI-first approach to therapeutic discovery and development.

Tecan Brings Agentic AI to the Lab Bench with NVIDIA-powered Introspect Upgrade

New capabilities aim to shift laboratories from reactive troubleshooting to proactive problem-solving, but the real test will be whether AI agents can earn scientists' trust.

Moving research out of the lab is key to UK life science success

Professor Chris Day explores why strengthening university commercialisation and supporting spinouts will be critical to securing the UK's position as a global life sciences leader.